Eagle Claw Capital Managment, LLC Abb Vie Inc. Transaction History
Eagle Claw Capital Managment, LLC
- $542 Million
- Q2 2024
A detailed history of Eagle Claw Capital Managment, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Eagle Claw Capital Managment, LLC holds 69,015 shares of ABBV stock, worth $14 Million. This represents 2.18% of its overall portfolio holdings.
Number of Shares
69,015
Previous 69,590
0.83%
Holding current value
$14 Million
Previous $12.7 Million
6.59%
% of portfolio
2.18%
Previous 2.35%
Shares
29 transactions
Others Institutions Holding ABBV
# of Institutions
3,771Shares Held
1.28BCall Options Held
13MPut Options Held
9.83M-
Vanguard Group Inc Valley Forge, PA171MShares$34.7 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.8 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.9 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.86 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $360B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...